Yijiyin

With the mission of "keeping everyone away from cancer earlier", Yijiyin leverages core gene technologies such as self-developed tumor gene methylation and liquid biopsy to develop and provide cancer early screening products and services featuring the four major advantages of "non-invasive, precise, early-stage, and affordable". Yijiyin vigorously introduces high-level talents from home and abroad. Its R&D team, mainly composed of Ph.D. holders in medicine and genetics, has strong scientific research capabilities and has obtained more than 50 national invention patents and software copyrights. The company focuses on the field of early screening of gastrointestinal cancers and has developed and laid out product pipelines including early screening of colorectal cancer, screening of gastric cancer pathogenic bacteria and medication guidance, anti-cancer gene testing, early screening of gastric cancer, early screening of liver cancer, and early screening of esophageal cancer, helping the public accurately and conveniently detect diseases early and resist health risks. Since its establishment in 2014, Yijiyin has successively obtained a series of important and comprehensive qualifications, including medical institution practice license, clinical tumor gene testing license (PCR laboratory qualification), National High-tech Enterprise, provincial-level R&D center, gene testing quality management system certification and other important qualifications, and has passed the external quality assessment of the National Center for Clinical Laboratories of the National Health Commission with full marks for many consecutive years. The company has an independent medical laboratory of 1,300 square meters on an entire floor, equipped with internationally advanced gene testing instruments such as Illumina NextSeqCN500, Pacbio Sequel, Applied Biosystems Ge-netitan, and ABI 7500, and has built a high-performance computing center, possessing an industry-leading gene testing software and hardware platform. Yijiyin is a key enterprise introduced and supported by the government. It has successively received top-level free entrepreneurship support from Hangzhou's "5050 Plan" and talent support from Zhejiang Province's "Ten Thousand Talents Plan", and has received over 100 million yuan in investment from listed testing equipment company Yuanfang Information (300306) and others. Yijiyin is committed to cooperating with physical examination institutions, primary medical institutions, hospitals, enterprises and institutions, providing partners with differentiated competitive products and high-quality customer service, helping partners further improve the service loop and enhance competitive advantages, and jointly contributing to the cause of national health. At present, it has established good cooperative relations with many top-tier hospitals in China, such as Peking Union Medical College Hospital, Fudan University Affiliated Hospital, Soochow University Affiliated * Hospital, Cancer Hospital Affiliated to University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), and Zhejiang University School of Medicine Affiliated * Hospital, helping more than 300,000 customers resist the threat of cancer to the greatest extent.